Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05572606 · ClinicalTrials.gov registry record · NA
Treatment of Symptomatic Bloating Using a Novel Hypnotherapy Protocol
A NA study of Bloating, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
- 1
- Study location
NCT05572606: Completed NA study of Bloating, sponsored by Mayo Clinic.
NCT05572606 is a NA study of Bloating that has completed, run by Mayo Clinic. The registered enrollment target is 27 participants, below the 98-participant average among 5 other Bloating trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05572606, a NA study of Bloating, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to evaluate if hypnotherapy delivered electronically will help with bloating symptoms.
Primary Outcome
Measured on a 0-100 scale using the bloating severity question of the the validated Irritable Bowel Syndrome Symptom Severity Scale (IBS-SSS)
Conditions Studied
Interventions
- BEHAVIORAL Hypnotherapy
Study Locations (1)
Minnesota
- Mayo Clinic Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2023-01-26 |
| Est. Completion | 2025-01-01 |
| Phase | NA |
What the finished NCT05572606 record still lists
NCT05572606 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 98-participant average among 5 other Bloating trials with a reported enrollment target (72% lower).
The record links to 1 condition, with Bloating appearing as the primary indexed condition, and to 1 intervention - of which Hypnotherapy is the first listed.
NCT05572606 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05572606 about?
NCT05572606 is a clinical study titled "Treatment of Symptomatic Bloating Using a Novel Hypnotherapy Protocol". The purpose of this research is to evaluate if hypnotherapy delivered electronically will help with bloating symptoms.
What is the current status of trial NCT05572606?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2023-01-26. Estimated completion is 2025-01-01.
What conditions does trial NCT05572606 study?
This clinical trial studies the following conditions: Bloating.
What interventions are being tested in trial NCT05572606?
The interventions under investigation include: Hypnotherapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT05572606?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05572606 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bloating
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Diaphragmatic Breathing for the Treatment of Bloating and Distension
RECRUITING · NA
-
Impact of the Inno Cleanse Dietary Supplement on Gut Health and Associated Variables in Healthy Men and Women
RECRUITING · NA
-
Study to Evaluate a Probiotic in Healthy Subjects With a History of Abdominal Discomfort and Bloating
COMPLETED · NA
-
A Study of Microbiome Transplantation for the Treatment of Constipation and/or Significant Bloating in Patients With Systemic Sclerosis
RECRUITING · Phase 2
-
A Study to Evaluate OPTI-BIOME™ Bacillus Subtilis MB40 on Abdominal Discomfort, Gas and Bloating in a Healthy Population
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI